Share on LinkedInShare on LinkedIn

ARTICLE · 08 DECEMBER 2017

Advances In Prosthetics Gathering Pace

Osteointegration prosthetics and bionics for amputees may start to pay dividends for insurers for the first time in 2018. Insurers' reluctance to fund new technology ...

United KingdomInsurance

Insurers could see the first signs of real financial savings

Osteointegration prosthetics and bionics for amputees may start to pay dividends for insurers for the first time in 2018. Insurers' reluctance to fund new technology, if not offset by lower care costs and reduced future losses (e.g. loss of earnings), may soon be a thing of the past.

The high level of military application for these technologies together with various prolonged conflicts has generated large cohorts of amputees. The resultant increase in demand has led to significantly faster product development. For example, in the last five years, bionic technology has developed from the knee to the ankle. This has resulted in higher limb costs, as twice the technology – both knee and ankle functionality – costs around £100k.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from